drugset / Trial / NCT04256018

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

NCT04256018

Phase 2 Recruiting 30 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy of the combination of LD-TSEBT and mogamulizumab in patients with MF and SS. And to evaluate the secondary measures of clinical benefit of the combination therapy and to evaluate the safety and tolerability of the combination in patients with MF and SS.

Timeline

Start
2020-03-30
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Mogamulizumab Monoclonal antibody 1 mg/kg Intravenous